Exchange
Date | Category
File | Description |
|---|
| BSE 30-Oct-2024 | General Announcements
FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication |
| BSE 28-Oct-2024 | General Announcements
FILE | Revision In Record Date For Entitlement Of Interim Dividend
Revision in Record Date for Entitlement of Interim Dividend |
| BSE 28-Oct-2024 | Intimation
FILE | Revision In Record Date For Interim Dividend
Revision in Record Date for Interim Dividend |
| BSE 24-Oct-2024 | Intimation
FILE | Corporate Action-Board to consider Dividend
The Board will consider declaration of Interim Dividend for the financial year 2024-25. |
| BSE 24-Oct-2024 | Intimation
FILE | Record Date For Dividend
The Company has decided to fix Friday 22nd November 2024 as the record date for the members entitlement of the Interim dividend that may be declared at the meeting of the Board of Directors on 14th November 2024. |
| BSE 24-Oct-2024 | Intimation
FILE | Board Meeting Intimation for Standalone And Consolidated Financial Results For 2Nd Quarter And Half Year Ended 30Th September 2024 And Declaration Of Interim Dividend
IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Standalone and Consolidated Financial Results for 2nd quarter and half year ended 30th September 2024 and Declaration of Interim Dividend |
| BSE 08-Oct-2024 | General Announcements
FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Reg 74(5) of SEBI (DP) Regulation 2018 for the quarter ended September 30 2024. |
| BSE 04-Oct-2024 | General Announcements
FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate Share Certificate |
| BSE 30-Sep-2024 | General Announcements
FILE | To Enter Into Agreements By Bayshore Pharmaceuticals LLC USA With Unichem Laboratories Limited And UnichemPharmaceuticals (USA) Inc So As To Integrate And Consolidate All The Ipca Group'S USA Generic Formulations Business Under One Entity
Consolidation / Integration of USA generics formulations business under Unichem Pharmaceuticals (USA) Inc. |
| BSE 30-Sep-2024 | Outcome
FILE | Board Meeting Outcome for To Enter Into Agreements By Bayshore Pharmaceuticals LLC USA With Unichem Laboratories Limited And Unichem Pharmaceuticals (USA) Inc So As To Integrate And Consolidate All The Ipca Group'S USA Generic Formulations Business Under One Entity
Entering into agreements by Bayshore Pharmaceuticals LLC USA (Bayshore) (wholly-owned step down subsidiary)with Unichem Laboratories Limited (Unichem India) (subsidiary company) and Unichem Pharmaceuticals (USA) Inc (Unichem USA) (wholly owned subsidiary of Unichem India) so as to integrate and consolidate all the Ipca Groups USA generic formulations business under one entity. |
| BSE 27-Sep-2024 | General Announcements
FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper publication |
| BSE 23-Sep-2024 | Intimation
FILE | Board Meeting Intimation for Integration And Consolidation Of The Generics Formulations Business In The US Market
IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2024 inter alia to consider and approve Integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned step-down subsidiary) into Unichem Pharmaceuticals (USA) Inc. (wholly owned subsidiary of Companys subsidiary) |
| BSE 23-Sep-2024 | Intimation
FILE | Closure of Trading Window
Closure of Trading Window |
| BSE 20-Sep-2024 | General Announcements
FILE | Announcement under Regulation 30 (LODR)-Change in Directorate
Completion of second term of 5 years as an Independent Director by Dr. (Ms.) Manisha Premnath. |
| BSE 20-Sep-2024 | General Announcements
FILE | Order Received From The Joint Commissioner (Appeals) CGST Jaipur Under Section 107 Of The CGST Act 2017
Order received from the Joint Commissioner (Appeals) CGST Jaipur under Section 107 of the CGST Act 2017 |
| BSE 18-Sep-2024 | General Announcements
FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificate |
| BSE 06-Sep-2024 | General
FILE | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HDFC Mutual Fund |
| BSE 02-Sep-2024 | General Announcements
FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate |
| BSE 19-Aug-2024 | General Announcements
FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Conference Call held on 14.08.2024 for Q1FY25 Results |
| BSE 14-Aug-2024 | General Announcements
FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Link for the Investors Conference Call held on 14.08.2024 |
| BSE 14-Aug-2024 | General Announcements
FILE | Approval Of Shareholders For Re-Appointment / Appointment Of Directors
Approval of shareholders for re-appointment / appointment of Directors |
| BSE 14-Aug-2024 | Outcome
FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results & Scrutinizer Report of the 74th Annual General Meeting held on 13th August 2024 |
| BSE 14-Aug-2024 | General Announcements
FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication |
| BSE 13-Aug-2024 | Outcome
FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 74th Annual General Meeting held on 13.08.2024 |
| BSE 13-Aug-2024 | Outcome
FILE | Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For Q1FY25
Standalone and Consolidated Unaudited Financial Results for Q1FY25 |
| BSE 13-Aug-2024 | Outcome
FILE | Standalone And Consolidated Unaudited Financial Results For Q1FY25
Standalone and Consolidated Unaudited Financial Results for Q1FY25 |
| BSE 07-Aug-2024 | General Announcements
FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Conference Call to discuss Q1FY25 Results |
| BSE 07-Aug-2024 | General
FILE | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kotak Mahindra Mutual Fund |
| BSE 06-Aug-2024 | General Announcements
FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release
Media Release for launch of patented novel drug branded "Diulcus in the Indian market for treatment of Diabetic Foot Ulcer (DFU) |
| BSE 26-Jul-2024 | General Announcements
FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate Share Certificate |
